AHR and thyroid cancer: Overall, these data suggested an involvement of kynurenine-induced AhR activation in conferring a more aggressive phenotype to thyroid cancer cells, by contributing to the onset of an immune-tolerant microenvironment and promoting cellular migration and invasiveness.